OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial.
Published in:
2021
By:
- Riddle, Matthew C.;
- Gerstein, Hertzel C.;
- Xavier, Denis;
- Cushman, William C.;
- Leiter, Lawrence A.;
- Raubenheimer, Peter J.;
- Atisso, Charles M.;
- Raha, Sohini;
- Varnado, Oralee J.;
- Konig, Manige;
- Lakshmanan, Mark;
- Franek, Edward
Publication type:
journal article
Cardiovascular outcomes trials with glucagon‐like peptide‐1 receptor agonists: A comparison of study designs, populations and results.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2209, doi. 10.1111/dom.14165
By:
- Pantalone, Kevin M.;
- Munir, Kashif;
- Hasenour, Clinton M.;
- Atisso, Charles M.;
- Varnado, Oralee J.;
- Maldonado, Juan M.;
- Konig, Manige
Publication type:
Article
Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide.
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1365, doi. 10.1111/dom.13662
By:
- Umpierrez, Guillermo;
- Pantalone, Kevin M.;
- Atisso, Charles M.;
- Landó, Laura Fernández;
- Patel, Hiren
Publication type:
Article
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes ( REWIND) trial on the cardiovascular effects of dulaglutide.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 42, doi. 10.1111/dom.13028
By:
- Gerstein, Hertzel C.;
- Colhoun, Helen M.;
- Dagenais, Gilles R.;
- Diaz, Rafael;
- Lakshmanan, Mark;
- Pais, Prem;
- Probstfield, Jeffrey;
- Riddle, Matthew C.;
- Rydén, Lars;
- Xavier, Denis;
- Atisso, Charles M.;
- Avezum, Alvaro;
- Basile, Jan;
- Chung, Namsik;
- Conget, Ignacio;
- Cushman, William C.;
- Franek, Edward;
- Hancu, Nicolae;
- Hanefeld, Markolf;
- Holt, Shaun
Publication type:
Article
Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
Published in:
Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0355-z
By:
- Ferdinand, Keith C.;
- Botros, Fady T.;
- Atisso, Charles M.;
- Sager, Philip T.
Publication type:
Article
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.
Published in:
Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01386-4
By:
- Konig, Manige;
- Riddle, Matthew C.;
- Colhoun, Helen M.;
- Branch, Kelley R.;
- Atisso, Charles M.;
- Lakshmanan, Mark C.;
- Mody, Reema;
- Raha, Sohini;
- Gerstein, Hertzel C.
Publication type:
Article
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Published in:
Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01179-1
By:
- Dagenais, Gilles R.;
- Rydén, Lars;
- Leiter, Lawrence A.;
- Lakshmanan, Mark;
- Dyal, Leanne;
- Probstfield, Jeffrey L.;
- Atisso, Charles Messan;
- Shaw, Jonathan E.;
- Conget, Ignacio;
- Cushman, William C.;
- Lopez-Jaramillo, Patricio;
- Lanas, Fernando;
- Munoz, Ernesto German Cordona;
- Pirags, Valdis;
- Pogosova, Nana;
- Basile, Jan;
- Sheu, Wayne H. H.;
- Temelkova-Kurktschiev, Theodora;
- Raubenheimer, Peter J.;
- Keltai, Matyas
Publication type:
Article
fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.
Published in:
Allergy, Asthma & Clinical Immunology, 2024, v. 20, n. 1, p. 1, doi. 10.1186/s13223-024-00904-9
By:
- Čižnár, Peter;
- Roderick, Marion;
- Schneiderova, Helen;
- Jeseňák, Miloš;
- Kriván, Gergely;
- Brodszki, Nicholas;
- Jolles, Stephen;
- Atisso, Charles;
- Fielhauer, Katharina;
- Saeed-Khawaja, Shumyla;
- McCoy, Barbara;
- Yel, Leman
Publication type:
Article
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1).
Published in:
Diabetes Care, 2014, v. 37, n. 8, p. 2159, doi. 10.2337/dc13-2760
By:
- Wysham, Carol;
- Blevins, Thomas;
- Arakaki, Richard;
- Colon, Gildred;
- Garcia, Pedro;
- Atisso, Charles;
- Kuhstoss, Debra;
- Lakshmanan, Mark
Publication type:
Article
924-P: Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND.
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-924-P
By:
- COLHOUN, HELEN M.;
- HASENOUR, CLINTON;
- RIDDLE, MATTHEW C.;
- BRANCH, KELLEY;
- KONIG, MANIGE;
- ATISSO, CHARLES;
- LAKSHMANAN, MARK;
- MODY, REEMA;
- GERSTEIN, HERTZEL C.
Publication type:
Article
356-OR: Effect of Dulaglutide on Kidney Function–Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial.
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-356-OR
By:
- SHAW, JONATHAN E.;
- BOTROS, FADY T.;
- MALIK, RALEIGH;
- ATISSO, CHARLES;
- COLHOUN, HELEN M.;
- GERSTEIN, HERTZEL C.
Publication type:
Article

Found: 11